While the majority of individuals suspected of having pulmonary hypertension would prefer to receive a physical examination to confirm diagnosis, invasive right heart catheterization may still offer the most reliable indication of diagnosis. “Utility of the Physical Examination in Detecting Pulmonary Hypertension: A Mixed Methods…
News
A research team from the University of Alberta, led by Dr. Evengelos Michelakis, claims to have found a link between Pulmonary Hypertension, diabetes, and cancer. PAH is a disease caused by a constriction of the arteries in the lung, forcing the right heart ventricle to work intensely. This causes…
In a study entitled “A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study” published in the November issue of Annals of the Rheumatic Diseases journal, the authors sought to understand the effects of gender on the systemic sclerosis phenotype…
In a recent study entitled “Accuracy of invasive arterial pressure monitoring in cardiovascular patients: an observational study” the authors suggest that when evaluating a patient’s cardiovascular system, a non-invasive blood pressure measurement may be more accurate than the standard invasive method to measure arterial pressure. Improved…
The Baltimore Walk for Hope is an upcoming event organized by the Pulmonary Hypertension Association (PHA) to raise awareness about pulmonary hypertension. The event will take place next Sunday, November 2nd at the Baltimore Zoo. The event is designed to be a 1.1 mile family and friendly walk…
In a study entitled “Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary disease” recently published in BMC Pulmonary Medicine, the authors of the research describe how their newly developed mean response time (MRT) index (wMRT), which is based on measuring oxygen uptake…
Naturally occurring microRNA molecules (miRNA) hold the potential to be a new treatment for pulmonary artery disease. A group at Sookmyung University and Yale University led by Professor Kim Jong-min investigated the causes of pulmonary arterial hypertension and discovered new molecular mechanism contributing to the disease. “Our research is…
Chloe Temtchine More support for pulmonary hypertension (PH) is expected to pour in next week during the Pulmonary Hypertension Association‘s (PHA) 2nd Annual O2 Breathe Gala. This year, one of the gala’s honored guests is YouTube sensation and singer-songwriter, Chloe Temtchine, who is…
A pair of nurses from the Stanford University Medical Center are set to conduct a live webinar on much-needed public awareness of clinical research — the most crucial and intensive phase in product and treatment development before achieving marketing approval and finally benefiting consumers and patients everywhere.
At the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Giessen University, a team of scientists under the leadership of Dr. Soni Savai Pullamsetti is uncovering potential reasons why pulmonary arteries become narrowed and lead to pulmonary hypertension. Recent experiments, highlighted in a…
The U.K.’s Chancellor of the Exchequer, George Osborne, has announced that the University of Sheffield will be awarded £7.5 million to expand development of its world-leading clinical lung imaging research — technology that may lead to significant advances in treating a wide range of pulmonary disease, including Pulmonary Hypertension.
To date, twelve therapies have been approved to treat pulmonary arterial hypertension (PAH). Of these, three were approved last year, indicating significant progress in understanding and treating PAH. These advancements were greatly needed, as according to the recent publication of “Pulmonary Arterial Hypertension: Progress and Challenges in…
